Achilles Therapeutics

NASDAQ: ACHL · Real-Time Price · USD
1.48
0.00 (0.00%)
At close: Mar 20, 2025, 3:59 PM

Achilles Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
131.54M 173.34M 266.32M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
33K 33K 33K
Other Long-Term Assets
2.21M 3.05M 3.54M
Receivables
10.35M 16M 11.17M
Inventory
n/a 4.62M 5.13M
Other Current Assets
1.98M 2.62M 2.12M
Total Current Assets
145.63M 196.58M 284.75M
Property-Plant & Equipment
13.54M 20.48M 28.79M
Goodwill & Intangibles
n/a -33K -33K
Total Long-Term Assets
15.82M 23.78M 32.36M
Total Assets
161.46M 220.36M 317.11M
Account Payables
5.63M 5.19M 3.72M
Deferred Revenue
n/a n/a 9.64M
Short-Term Debt
n/a n/a n/a
Other Current Liabilities
965K 1.75M 1.98M
Total Current Liabilities
17M 17.99M 19.11M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
1.01M 933K 691K
Total Long-Term Liabilities
2.09M 5.32M 8.47M
Total Liabilities
19.09M 23.31M 27.58M
Total Debt
4.62M 8.58M 12.26M
Common Stock
182K 54K 54K
Retained Earnings
-259.95M -190.29M -119.11M
Comprehensive Income
-13.07M -21.7M 6.64M
Shareholders Equity
142.37M 197.04M 289.53M
Total Investments
33K 33K 33K